These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18172537)

  • 1. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
    Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
    Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep vein thrombosis after recombinant factor VIIa infusion to control severe recurrent postoperative bleeding.
    Pépion C; Becq MC; Jacob L
    Anesthesiology; 2006 Apr; 104(4):892-3. PubMed ID: 16571994
    [No Abstract]   [Full Text] [Related]  

  • 4. Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome?
    Saeed G; Ganster G; Friedel N
    Tex Heart Inst J; 2008; 35(3):373-4; author reply 374-6. PubMed ID: 18941643
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
    Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
    Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
    Al-Ruzzeh S; Ibrahim K; Navia JL
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant activated factor VII for perioperative bleeding].
    López R; Aeschlimann N; Carvajal C; Lema G
    Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
    Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
    Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
    Johnson SJ; Ross MB; Moores KG
    Am J Health Syst Pharm; 2007 Sep; 64(17):1808-12. PubMed ID: 17724361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric off-label use of recombinant factor VIIa.
    Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
    Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
    Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
    J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk assessment of thrombotic events after the use of activated factor VII].
    Martínez López MC; Alcaraz Romero AJ; Martínez López AB; Fernández-Llamazares CM; Ramos Navarro C
    An Pediatr (Barc); 2013 Sep; 79(3):177-81. PubMed ID: 23265723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro: The role of recombinant factor VIIa in cardiac surgery.
    Karkouti K; Beattie WS
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):779-82. PubMed ID: 18922442
    [No Abstract]   [Full Text] [Related]  

  • 17. Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
    Hong I; Stachnik J
    Am J Health Syst Pharm; 2010 Nov; 67(22):1909-19. PubMed ID: 21048207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
    Culić S; Kuljis D; Armanda V; Jankovic S
    Pediatr Blood Cancer; 2007 Sep; 49(3):332-5. PubMed ID: 16514611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery.
    von Heymann C; Hotz H; Konertz W; Kox WJ; Spies C
    J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):615-6. PubMed ID: 12407617
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
    Gill R; Herbertson M; Vuylsteke A; Olsen PS; von Heymann C; Mythen M; Sellke F; Booth F; Schmidt TA
    Circulation; 2009 Jul; 120(1):21-7. PubMed ID: 19546387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.